Share Name Share Symbol Market Type Share ISIN Share Description
Spire Healthcare Group Plc LSE:SPI London Ordinary Share GB00BNLPYF73 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -1.70 -1.34% 125.00 596,289 16:35:05
Bid Price Offer Price High Price Low Price Open Price
123.90 126.60 129.70 122.70 129.70
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 931.10 8.20 2.80 44.6 501
Last Trade Time Trade Type Trade Size Trade Price Currency
17:04:55 O 3,631 124.994 GBX

Spire Healthcare (SPI) Latest News

More Spire Healthcare News
Spire Healthcare Takeover Rumours

Spire Healthcare (SPI) Share Charts

1 Year Spire Healthcare Chart

1 Year Spire Healthcare Chart

1 Month Spire Healthcare Chart

1 Month Spire Healthcare Chart

Intraday Spire Healthcare Chart

Intraday Spire Healthcare Chart

Spire Healthcare (SPI) Discussions and Chat

Spire Healthcare Forums and Chat

Date Time Title Posts
18/10/201912:09Spire Health1,166
15/1/201713:48Spice Holdings PLC1,547
07/10/201102:44Stanard and Very Poor-
31/1/201018:33Man, a spiritual being or an animal?192
12/8/200011:36Spirent PLC-

Add a New Thread

Spire Healthcare (SPI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2019-10-21 16:04:55124.993,6314,538.53O
2019-10-21 16:03:26125.051,9522,440.98O
2019-10-21 15:35:05125.00243,994304,992.50UT
2019-10-21 15:29:56125.907189.39O
2019-10-21 15:29:55125.206682.63AT
View all Spire Healthcare trades in real-time

Spire Healthcare (SPI) Top Chat Posts

DateSubject
21/10/2019
09:20
Spire Healthcare Daily Update: Spire Healthcare Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker SPI. The last closing price for Spire Healthcare was 126.70p.
Spire Healthcare Group Plc has a 4 week average price of 108.20p and a 12 week average price of 95.25p.
The 1 year high share price is 141.30p while the 1 year low share price is currently 95.25p.
There are currently 401,081,391 shares in issue and the average daily traded volume is 639,172 shares. The market capitalisation of Spire Healthcare Group Plc is £501,351,738.75.
26/9/2019
20:54
sza2002: I don't think you read the article past the headlines. This is only going to stop the CCG's tendering out small value services. It will not increase capacity to tackle the existing deficit which is prolonging waiting times. To increase capacity in the NHS which has been allowed to wither will take years. I think private sector will be playing a key role. You can get private medical insurance for £10.25 per month from the likes of Benenden Health(hxxps://www.benenden.co.uk/)which is very affordable. I see a bright future for Spire. Share price is at a great entry point if you are not invested. I have a small holding so I may be biased.
10/9/2019
12:09
justiceforthemany: 125p now hit. Mdc flat. Bidders share price normally drops on takeover.
01/3/2019
20:10
eaaxs06: A good day for the share price, let's hope for more of the same next week. Short term target now is 141.3p Good luck everyone, Sid.
14/10/2018
15:50
cantrememberthis2: Mediclinic last year had to write down £105m+ last year when share price was £2.25, from their initial 300p+ investment and stake of 29%. Do they write down another £120m from last year to todays share price circa 125p? Seems absurd when they COULD buy the remaining shares at substantially less than 300p, 225p in some ways. Why write off another £120m, on top of the £105m+ from previous years... i.e. £225m write down? Wow, you can by out some serious companies on the FTSE at the £250m region!!! Well,either way its been a VERY EXPENSIVE LESSON. Spire Healthcare on its knees at 125 from concerted shorting by the likes of Wallace LLP etc... who have shorted regularly from Mid Aug to as late as 8th Oct 18. The scenario created here through bad timing, NHS cost reductions and market apathy = OPPORTUNITY for others. MDC report 17OCT18. Also their CEO sits on the SPI board. Call me thick - but this is takeover territory and IF MDC are too slow to react could cost them with a predator lurking! Game on GLA, DYOR.
03/10/2018
13:25
essentialinvestor: What are the negative comments?. At the tine of the bid I said Spire would be better to accept, and the sector faced challenges with cost pressures re margins, which may be underestimated. Posted that view long before the recent warning. Which of those has been incorrect, given recent results and a share price collapse since. Recently mentioned Spire now looked a sitting duck for a bid, however there's no guarantee. If you view any of that as negative, you are a very sensitive soul.
30/9/2018
17:45
justiceforthemany: THE TIMES Meet the companies ripe for a share grab Spire Healthcare “Mediclinic217;s management will probably sigh with relief that they didn’t go ahead with a full takeover of Spire last year because the company’s shares have continued to slide. They briefly touched £1.50 a share after this week’s trading update and profit warning as NHS referrals dropped more than expected. The lower share price could tempt Mediclinic, which already owns 29.5 per cent, to return with a new offer, with Spire shareholders more willing to accept a price below last year’s offer price.”
28/9/2018
09:24
eastbourne1982: Ebitda has changed though and as a result the bank covenants are going to become an issue soon, this is one of the main reasons for the share price fall, anything could happen here, you could get a bid however the share price could also go sub £1. A possible bid is the only positive in the short term, there are many negatives.
09/8/2018
18:40
jonwig: In the meantime, we downgrade our 2018 EBITDA by 16% and EPS by 37%, noting that this implies gearing of 3.7x EBITDA at the end of 2018 (covenant 4.0x). With the shares down by 20% since our upgrade, our waning confidence in our prior investment thesis prompts us to consider a stop-loss action. Our new valuation, based on EV/EBITDA and DCF metrics that reflect higher risk, leads to a 120p/share price target. We therefore set our recommendation to Sell, and believe there is potential for intangible asset write-downs and a dividend cut. Speculation regarding the potential for Mediclinic to acquire Spire helps to the limit downside, but Mediclinic’s five-year low share price, and the negative reaction to its previous bid for Spire, adds risk to relying on that get-out-of-jail-free card.
29/12/2017
09:14
che7win: Yes bounty, MDC might be barred from takeover for 6months, not sure, or unless someone else comes in with an offer.But nothing to stop others taking this over, plenty of US companies could use a weak exchange rate in their favour, never mind a weak SPI share price to offer 350p a share.Who knows, the chart has broken out from the low point though, would be nice to get to 300p from here short term.
16/9/2016
14:07
tonysss13: Mediclinic said to weigh £1.8 billion plus takeover bid for Spire Healthcare Friday, 16 September 2016, 11:03 am Mediclinic is preparing to bid for Spire Healthcare, the FTSE 250 company that was formed from the sale of BUPA hospitals. According to excellent sources, Mediclinic is working with bankers from Morgan Stanley on the potential purchase of the remainder of Spire Healthcare that it doesn't own (remember last year Mediclinic bought 29.9pc of Spire Healthcare for 360p a share). Now, to be clear I'm not the first financial journalist to raise the prospect of a Mediclinic bid for Spire Healthcare. In late August, several British stock market reporters picked up on a note from JP Morgan, which theorised that now might be the right time for FTSE 100-listed Mediclinic to buy the remainder of Spire given the currency fluctuations post the Brexit referendum. I have pasted the relevant paragraphs from the JP Morgan note below: "In our view, the weakness in the GBP and strength of MDC’s share price vs Spire’s is an opportunity for MDC to consolidate its ownership of Spire (currently 29.9%). We estimate it could pay a 35% premium for Spire and see year one EPS increase by 3-4%, rising to 10% in year three assuming a debt-based deal. Alternatively, if MDC chose to raise equity ~£300m-500m (4-7%) in order to leave less gearing and also fund Spire’s London hospital expansion, year one accretion would drop to 2-1%. We note the authority to raise equity afforded Remgro, MDC’s largest shareholder (~44.6%), at its Aug-16th AGM." But from what I understand from excellent sources is bankers from Morgan Stanley, Mediclinic's financial advisers, are actually working on the deal suggested by the JP Morgan analyst. One source reckons Mediclinic is just a few weeks away from submitting a formal approach for Spire. I don't have much more information than that but I have been told any offer is likely to be at about a 30pc premium to the current share price. Mediclinic declined to comment. However, people familiar with the company tried to play down the tale, unsurprisingly. - See more at: hxxp://www.betaville.co.uk/news/mediclinic-said-to-be-preparing-1.5-billion-plus-bid-for-spire-healthcare/#sthash.7inBYdLQ.dpuf
Spire Healthcare share price data is direct from the London Stock Exchange
Your Recent History
LSE
SPI
Spire Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191022 05:46:56